相似文献
1
Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.
J Med Chem. 2006 Jan 12;49(1):27-30. doi: 10.1021/jm050892j.
2
Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.
Bioorg Med Chem Lett. 2006 Mar 15;16(6):1527-31. doi: 10.1016/j.bmcl.2005.12.038. Epub 2006 Jan 4.
3
QSAR and molecular docking studies of lethal factor protease inhibitors against .
SAR QSAR Environ Res. 2019 Oct;30(10):715-731. doi: 10.1080/1062936X.2019.1658219. Epub 2019 Sep 26.
4
Rhodanine derivatives as selective protease inhibitors against bacterial toxins.
Chem Biol Drug Des. 2008 Feb;71(2):131-9. doi: 10.1111/j.1747-0285.2007.00617.x. Epub 2008 Jan 19.
5
Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.
Bioorg Med Chem. 2009 May 1;17(9):3352-68. doi: 10.1016/j.bmc.2009.03.040. Epub 2009 Mar 26.
6
Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.
Bioorg Med Chem Lett. 2006 Oct 1;16(19):5183-9. doi: 10.1016/j.bmcl.2006.07.005. Epub 2006 Jul 25.
7
The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor.
Nat Struct Mol Biol. 2004 Jan;11(1):60-6. doi: 10.1038/nsmb708. Epub 2003 Dec 29.
8
The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors.
Biochem J. 1996 Dec 1;320 ( Pt 2)(Pt 2):687-91. doi: 10.1042/bj3200687.
9
Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.
Biochem Biophys Res Commun. 2011 Jan 7;404(1):517-22. doi: 10.1016/j.bbrc.2010.12.015. Epub 2010 Dec 6.
10
Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.
Chem Biol. 2012 Jul 27;19(7):875-82. doi: 10.1016/j.chembiol.2012.05.013.
引用本文的文献
1
Design and use of a novel substrate for simple, rapid, and specific early detection of anthrax infection.
PLoS One. 2018 Nov 9;13(11):e0207084. doi: 10.1371/journal.pone.0207084. eCollection 2018.
2
Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors.
J Mol Graph Model. 2016 Jan;63:22-8. doi: 10.1016/j.jmgm.2015.11.008. Epub 2015 Nov 17.
3
Statistical analysis, optimization, and prioritization of virtual screening parameters for zinc enzymes including the anthrax toxin lethal factor.
Curr Top Med Chem. 2014;14(18):2105-14. doi: 10.2174/1568026614666141106163011.
4
Small molecule inhibitors of anthrax lethal factor toxin.
Bioorg Med Chem. 2014 Jan 1;22(1):419-34. doi: 10.1016/j.bmc.2013.11.009. Epub 2013 Nov 13.
5
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
J Med Chem. 2012 Sep 27;55(18):7998-8006. doi: 10.1021/jm300804e. Epub 2012 Sep 18.
6
Development of a novel class of B-Raf(V600E)-selective inhibitors through virtual screening and hierarchical hit optimization.
Org Biomol Chem. 2012 Sep 28;10(36):7402-17. doi: 10.1039/c2ob26081f.
7
Development of a comprehensive, validated pharmacophore hypothesis for anthrax toxin lethal factor (LF) inhibitors using genetic algorithms, Pareto scoring, and structural biology.
J Chem Inf Model. 2012 Jul 23;52(7):1886-97. doi: 10.1021/ci300121p. Epub 2012 Jun 25.
8
3-Phenyl-2-thioxo-1,3-thia-zolidin-4-one.
Acta Crystallogr Sect E Struct Rep Online. 2008 Sep 24;64(Pt 10):o1998. doi: 10.1107/S1600536808030079.
9
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
J Med Chem. 2011 Jan 27;54(2):591-602. doi: 10.1021/jm101266s. Epub 2010 Dec 28.
10
A novel pharmacophore model for the design of anthrax lethal factor inhibitors.
Chem Biol Drug Des. 2010 Sep 1;76(3):263-8. doi: 10.1111/j.1747-0285.2010.01000.x. Epub 2010 Jun 21.
本文引用的文献
1
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.
J Am Chem Soc. 1988 Aug 1;110(18):5959-67. doi: 10.1021/ja00226a005.
2
3
Prediction of water and metal binding sites and their affinities by using the Fold-X force field.
Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10147-52. doi: 10.1073/pnas.0501980102. Epub 2005 Jul 8.
4
Efficient synthetic inhibitors of anthrax lethal factor.
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9499-504. doi: 10.1073/pnas.0502733102. Epub 2005 Jun 27.
5
Anthrax lethal factor inhibition.
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7958-63. doi: 10.1073/pnas.0502159102. Epub 2005 May 23.
6
CoMFA 3D-QSAR analysis of HIV-1 RT nonnucleoside inhibitors, TIBO derivatives based on docking conformation and alignment.
J Chem Inf Comput Sci. 2004 Nov-Dec;44(6):2167-78. doi: 10.1021/ci049893v.
7
Observations on experimental anthrax; demonstration of a specific lethal factor produced in vivo by Bacillus anthracis.
Nature. 1954 May 8;173(4410):869-70. doi: 10.1038/173869a0.
8
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5170-4. doi: 10.1073/pnas.0431098100. Epub 2003 Apr 16.
9
Anthrax X-rayed: new opportunities for biodefence.
Trends Pharmacol Sci. 2002 Dec;23(12):539-41. doi: 10.1016/s0165-6147(02)02127-2.
10
Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition.
Science. 2002 Sep 20;297(5589):2048-51. doi: 10.1126/science.1073163. Epub 2002 Aug 29.
Zotero 插件